ABOUT US

At CytoGenomic we believe that knowledge is power.

CytoGenomic Medical Laboratory specializes in next-generation diagnostic genetic testing. Applying the latest in technology, the lab provides a full range of services in clinical genetics, molecular genetics, cytogenetics and prenatal genetic screening aimed at detecting, assessing, treating, and preventing disease.

The DNA Spirit. Using science to live life to the fullest

“As a reference point for the most well-researched provision of genetic services and analyses in the country and in other Southeastern European regions, CytoGenomic Medical Laboratory takes pride in its leading role in providing accurate findings to the medical community and accessible healthcare to the people of Romania.
As diagnostic genetics continue to advance, it is our duty to remain dedicated to making its services easily accessible to all. Our aim is to employ developments in the field in the best interests of the community as a whole.”


Danae Stambouli, PhD., CytoGenomic Medical Laboratory

OUR VALUES

Do you want a better future for yourself, your children and their children? Then look no further.

You hold the future in your DNA. It answers questions. It explains. It predicts.
Our mission? To make the knowledge about your genes and their insight easily accessible and understandable.

We are dedicated to applying the latest developments in genetics and biotechnology in the best interests of the community, making its services accessible to all, and empowering individuals to make informed health decisions toward the highest standard of living.
Looking ahead, as an innovator in the field of genetics, CytoGenomic Medical Laboratory is constantly expanding its focus, diversifying its services, and introducing innovative products that will pave the way for targeted medicines and personalized healthcare.

OUR TEAM

EXPANDED NEONATAL SCREENING DEPARTMENT

Dr. MARIA IULIA GICA MD, Ph.D.
ISABELA ȚÂRCOMNICU Ph.D.CHEMIST
DANIELA BOCANCEA MSc CHEMIST
TINCUȚA CÂJU MSc CHEMIST

LAB DEPARTMENT

Dr.RODICA MARIA SIMION – MEDICAL CHIEF LABORATOR

DEPARTMENT OF RESEARCH-DEVELOPMENT

DANAI STAMBOULI Ph.D. – SCIENTIFIC CONSULTANT

GENETIC DEPARTMENT

DR. FLORINA NEDELEA MD, Ph.D. DR. ANCA NEACȘU MD ANCA PAVELMSc BIOLOGIST ANDREEA ȚUȚULAN-CUNIȚĂ – Ph.D.BIOLOGIST ELIZA RENȚEA MSc BIOLOGIST GEORGIANA LUNGUMSc BIOLOGIST LUIZA DIMOS MSc BIOCHEMIST
For the first time in Romania, our modern cytogenetics department provides the latest technologies in terms of diagnosis screening, while shifting prenataldiagnosis during the first trimester of pregnancy by analysing chorionic villus sampling (CVS). The quick and highly accurate method QF-PCR (Quantitative Fluorescence-PCR) is introduced at the same time for the prenatal detection of viable trisomies.
2008
2009
CytoGenomic Laboratory introduces during this year the prenatal biochemical screening (double and triple test) using the highly accurate and largely reproducible method certified by the Foetal Medicine Foundation (FMF) in London due to the Kryptoranalyser used for serologic determinations producing fast and accurate results in merely 24 hours. This test aims at identifying pregnancies with a high risk of Down syndrome and other chromosomal abnormalities and neural tube defects (spina bifida).
A new premiere for Romania, the launching of the Expanded NewbornScreening for Inherited Metabolic Disorders using HPLC MS/MS, a scientific innovation allowing the simultaneous early detection of 51 metabolic disorders, a set of serious conditions with irreversible symptoms.
2011
2013
The lab introduces the array-CGH Molecular Karyotype, an advanced prenatal and postnatal cytogenetic diagnosis method identifying submicroscopic chromosomal abnormalities, which cannot be identified using the traditional karyotype.
CytoGenomic Laboratory became the official partner of Ariosa Diagnostics (USA) for providing to Romania the maternal blood-based non-invasive screening Harmony for identifying the aneuploidies of chromosomes 13, 18, 21, X, and Y.
2013
2015
A new premiere for Romania - CytoGenomic Laboratory supports subfertile couples by introducing a new technique, the Pre-implantation genetic screening (PGS), performed prior to transferring the embryos in order to improve the success rate of the IVF procedure.
Extended Pre-eclampsia Screening: Starting from this year, at the CytoGenomic Laboratory, one mere peripheral blood sample is enough to determine the level of the PlGF placental marker and to estimate the risk for early detection of pre-eclampsia during the first trimester of pregnancy, this test being performed at the same time as the double test.
2016
2017
We passed from Genetics to Genomics by implementing cutting-edge SNP microarray and sequencing technologies. CytoGenomic Laboratory is the only laboratory in Romania to use genomic analyses Affymetrix (SNP microarray) and Ion S5 (NGS) platforms, which help us open the door for the modern concept of personalized medicine. NGS sequencing helps analysing the whole exome – around 19,000 genes and 5,000 disorders in any medical specialty (cardiology, neurology, orthopaedics, ophthalmology, metabolic diseases, gastroenterology, nephrology, etc.).
Once again, here we are to help the couples asking for In Vitro Fertilization by introducing Pre-implantation genetic diagnosis to identify monogenic disorders (PGD) for the first time in Romania using the NGS technology. This diagnosis is useful for couples bearing mutations to avoid transmitting them to their children. By testing the embryos obtained by In Vitro Fertilization, we can thus ensure the transfer of merely those embryos which are not affected, increasing these couples’ chances to have healthy children.
2018
2020
Soon, a new test!

COLABORATORI